Comparison study of the effectiveness of elemental diet during chemotherapy in patients with advanced pancreatic cancer

Comparison study of the effectiveness of elemental diet during chemotherapy in patients with advanced pancreatic cancer - Comparison study of the effectiveness of elemental diet during chemotherapy in patients with advanced pancreatic cancer

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000028659

Enrollment

Registered

2017-08-15

Start date

2017-08-15

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic cancer

Interventions

Patients administered elemental diet (1-2 packs per a day) for 3 month during chemotherapy Patients administer chemotherapy without nutritional therapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients receiving chemotherapy for unresectable advance pancreatic cancer. Patients gave a consent to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Age under 20 years 2. Allergy to Elental 3. Sever diabetes 4. Pregnant or breastfeeding women 5. Patients with amino acid disorder 6. Patients whom physician considered unqualifiable

Design outcomes

Primary

Measure	Time frame
overall survival	—

Secondary

Measure	Time frame
Body weight, body composition, Plasma protein, CA 19-9, ECOG PS, QOL, Adverse events and tolerability of chemotherapy, Progression-free survival (PFS), Dietary Intake	—

Countries

Japan

Contacts

Public ContactShinya Uemura

Gifu University Hospital First Dept. of Internal Medicine

ueshin550621@gmail.com058-230-6308

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Sep 19, 2026